Mirum Pharmaceuticals Funding & Investors
Mirum Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops therapies for the treating of cholestatic liver diseases. Mirum Pharmaceuticals serves patients in the United States.
mirumpharma.comTotal Amount Raised: $497,000,000
Mirum Pharmaceuticals Funding Rounds
Series A
$120,000,000
Series A Investors
New Enterprise Associates (NEA)Deerfield Capital ManagementFrazier ManagementNovo HoldingsPappas CapitalRiverVestRock Springs CapitalChiesi VenturesPost Ipo Equity
$275,000,000
Post Ipo Equity
$10,000,000
Post Ipo Equity Investors
Oberland CapitalPost Ipo Equity
$92,000,000
Funding info provided by Diffbot.